glp-1 glp-2 dual agonist The current significance and prospects for the use of receptor agonism GLP-1/Glucagon Science Behind GLP 1 GIP

Simultaneously, this study highlights the critical considerations for clinicians in administering these medications, including long-term safety, efficacy, potential adverse effects, and overall clinical utility

Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims

AT has received honoraria from Boehringer Ingelheim Japan, Mochida, and Amgen

A notable study showcased that participants receiving GLP-1 agonists reported a mean weight loss ranging between 3.0 and 3.6 kg over six months

Front Genet

(2025) 27:e70015